A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers
CGIZ943A12101
Phase 1 other active
Quick answer
A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers for Advanced high-grade serous ovarian cancer (OC), Locally advanced unresectable or metastatic non-squamous non-small cell lung carcinoma (NSCLC) is a Phase 1 program (other) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Advanced high-grade serous ovarian cancer (OC), Locally advanced unresectable or metastatic non-squamous non-small cell lung carcinoma (NSCLC)
- Phase
- Phase 1
- Modality
- other
- Status
- active